Anavex Life Sciences
AVXL
#8378
Rank
NZ$0.54 B
Marketcap
NZ$5.83
Share price
-2.85%
Change (1 day)
-67.63%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -NZ$68.28 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. , an increase over its 2024 earnings that were of -NZ$88.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$68.43 Million-22.43%
2024 -NZ$88.21 Million14.77%
2023 -NZ$76.86 Million-17.49%
2022 -NZ$93.15 Million22.96%
2021 -NZ$75.76 Million35.36%
2020 -NZ$55.97 Million12.65%
2019 -NZ$49.68 Million29.09%
2018 -NZ$38.49 Million36.33%
2017 -NZ$28.23 Million17.11%
2016 -NZ$24.11 Million20.91%
2015 -NZ$19.94 Million-6.29%
2014 -NZ$21.28 Million337.28%
2013 -NZ$4.87 Million
2008 -NZ$9 Million106.01%
2007 -NZ$4.37 Million8848.98%
2006 -NZ$0.05 Million-79.99%
2005 -NZ$0.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$0.32 B-576.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
-NZ$14.07 Million-79.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$10.68 Million-84.39%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.78 Billion 1,035.69%๐Ÿ‡บ๐Ÿ‡ธ USA